Celebrating Scientific Advancement Amarin applauds the groundbreaking work addressing sHTG and rare genetic disorders such as familial chylomicronemia syndrome (FCS). These advances help drive patient ...
While the effect of VASCEPA on the risk of pancreatitis in patients with sHTG has not been determined, data from the Company’s pivotal MARINE study in patients with TGs between 500 and 2,000 mg/dL, ...
A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) levels and cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback